BamSEC and AlphaSense Join Forces
Learn More

4D Molecular Therapeutics Inc.

NASDAQ: FDMT    
Share price (12/20/24): $6.31    
Market cap (12/20/24): $292 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 14 pages 4D Molecular Therapeutics, Inc. [Form Of] Warrant to Purchase Shares of Common Stock
12/34/56
EX-4.4
from 10-Q 14 pages 4D Molecular Therapeutics, Inc. [Form Of] Warrant to Purchase Shares of Common Stock
12/34/56
EX-4.1
from 8-K 11 pages 4D Molecular Therapeutics, Inc. [Form Of] Warrant to Purchase Shares of Common Stock
12/34/56
EX-4.3
from S-3ASR 52 pages 4D Molecular Therapeutics, Inc. Indenture Dated as of , 20___ [ ] Trustee
12/34/56
EX-4.5
from S-3 52 pages 4D Molecular Therapeutics, Inc. Indenture Dated as of , 20___ [ ] as Trustee
12/34/56
EX-4
from 10-K 7 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from S-3 51 pages 4D Molecular Therapeutics, Inc. Indenture Dated as of , 20 [ ], as Trustee
12/34/56
EX-4.1
from 10-K 7 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from S-1/A 72 pages 4D Molecular Therapeutics, Inc. Third Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4.2
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.3
from S-1 72 pages 4D Molecular Therapeutics, Inc. Third Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4.3
from S-1 78 pages 4D Molecular Therapeutics, Inc. Second Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4.3
from DRS 78 pages 4D Molecular Therapeutics, Inc. Second Amended and Restated Investors’ Rights Agreement
12/34/56